Compare CRVS & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRVS | TIGR |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2016 | 2018 |
| Metric | CRVS | TIGR |
|---|---|---|
| Price | $14.50 | $6.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $28.20 | $14.20 |
| AVG Volume (30 Days) | 1.1M | ★ 2.5M |
| Earning Date | 05-07-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.74 |
| Revenue Next Year | N/A | $13.91 |
| P/E Ratio | ★ N/A | $9.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.54 | $5.95 |
| 52 Week High | $26.95 | $13.55 |
| Indicator | CRVS | TIGR |
|---|---|---|
| Relative Strength Index (RSI) | 45.22 | 35.87 |
| Support Level | $12.95 | N/A |
| Resistance Level | $18.73 | $8.77 |
| Average True Range (ATR) | 0.94 | 0.28 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 51.17 | 26.21 |
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.